Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis
Stopped Manufacturer ceased to produce vials used for this study.
Conditions
- Palmo-Plantar Pustular Psoriasis
- Palmo-Plantar Pustulosis
Interventions
- DRUG: Ustekinumab
- DRUG: Placebo (Soduim Chloride)
Sponsor
Innovaderm Research Inc.
Collaborators